Litcius/Paper detail

Real-world effectiveness and safety of ixazomib-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

Evangelos Terpos, Karthik Ramasamy, Nadjoua Maouche, Jiří Minařík, Ioannis Ntanasis‐Stathopoulos, Eirini Katodritou, Matthew Jenner, Hana Plonková, Maria Gavriatopoulou, Grant Vallance, Tomáš Pika, Maria Kotsopoulou, Jaimal Kothari, Tomáš Jelı́nek, Efstathios Kastritis, Robin Aitchison, Meletios Α. Dimopoulos, Athanasios Zomas, Roman Hájek

2020Annals of Hematology41 citationsDOI

Topics & Concepts

LenalidomideIxazomibMultiple myelomaDexamethasoneMedicineHematologyInternal medicineOncologyCarfilzomibMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsMyeloproliferative Neoplasms: Diagnosis and Treatment